multiple sclerosis

An envelope with rejected mark Vector illustration
Biotech

FDA shares CRL for Sanofi MS drug mere weeks after rebuff

Less than two weeks after rejecting Sanofi’s investigational MS drug, the FDA has shared the CRL, citing both efficacy and safety concerns.
Gabrielle Masson Jan 6, 2026 4:30am
Stop sign

FDA rejects Sanofi MS drug, Corcept Cushing's syndrome therapy

Jan 2, 2026 7:10am
Sanofi

Sanofi's tolebrutinib woes pile up with FDA delay, trial miss

Dec 15, 2025 9:30am
arrow miss target fail attempt try

Contineum-J&J drug fails to improve vision in phase 2 MS trial

Nov 20, 2025 5:26pm
Image comparing healthy and degraded myelin sheath

Roche reports phase 3 multiple sclerosis wins for BTK inhibitor

Nov 10, 2025 6:26am
target reach ladder climb meet win beat competition

Zenas autoimmune drug prompts 95% drop in lesions in MS study

Oct 27, 2025 9:25am